Differentials

Your Organizational Guidance

ebpracticenet urges you to prioritize the following organizational guidance:

Aanhoudende hoest bij kinderen in de eerste lijnPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2017La toux prolongée chez l’enfant en première ligne de soinsPublished by: Groupe de Travail Développement de recommmandations de première ligneLast published: 2017
SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Dyspnea, expiratory wheeze, nasal polyposis.

INVESTIGATIONS

spirometry may show evidence of impaired lung function (FEV₁ <80% of predicted; FEV₁/FVC ratio <80% of predicted); peak expiratory flow shows >20% variability; fractional exhaled nitric oxide >40 parts per billion (ppb) in a corticosteroid-naive adult; methacholine bronchial challenge test may be useful in excluding asthma.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Sputum production (may be bloody), hemoptysis, dyspnea, fever, crackles or rhonchi on lung auscultation.

INVESTIGATIONS

Chest x-ray may be normal or show obscured hemidiaphragm, thin-walled ring shadows with or without fluid levels, tram lines, or tubular or ovoid opacities.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Heartburn, indigestion, cough with phonation, on eating, on bending over, or on first becoming ambulatory in the morning; may coexist with upper airway cough syndrome (UACS).

INVESTIGATIONS

Proton-pump inhibitor trial relieves symptoms; atypical symptoms (e.g., hoarseness) warrant further investigation (e.g., endoscopy may show esophagitis).

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

History of smoking.

Dyspnea that occurs with or without wheezing and coughing.

Exam may show barrel chest, hyper-resonance to percussion, and distant breath sounds.

INVESTIGATIONS

FEV₁/FVC<0.7; low oxygen saturation on pulse oximetry; FBC may show polycythemia (hematocrit >55%), anemia, and leukocytosis; chest x-ray shows hyperinflation.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Includes interstitial lung disease, ACE inhibitor use, and eosinophilic bronchitis.

Symptoms vary depending on the condition.

Interstitial lung disease: fatigue, weight loss, dyspnea, crackles on lung auscultation.

ACE inhibitor use: Dry cough beginning within days/month of starting ACE inhibitor therapy, tickling/scratching sensation in the throat.

Nonasthmatic eosinophilic bronchitis: chronic nonproductive cough.

INVESTIGATIONS

Interstitial lung disease: CXR shows basilar, peripheral, bilateral, asymmetric, or reticular opacities.

ACE inhibitor use: Resolution of cough on stopping ACE inhibitor.

Nonasthmatic eosinophilic bronchitis: eosinophilia on broncho-alveolar lavage (BAL) differential count; fractional exhaled nitric oxide elevated; therapeutic response to corticosteroids present.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Rhinorrhea/persistent clear nasal discharge.

Sneezing.

Intermittent nasal blockage.

Nasal pruritus.

Conjunctivitis.

Unilateral nasal symptoms, facial pain, thick green discharge, recurrent nosebleeds, or persistent loss of smell warrant further assessment.[36]

INVESTIGATIONS

Allergen skin-prick testing: wheal and flare reaction after specific allergen is introduced into the skin.

Specific aeroallergen radioallergosorbent test (RAST): positive.

These tests can establish the presence of atopy; however, it can be difficult to be certain that the chronic cough in UACS is arising from an allergic mechanism.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Occupational exposure or exposure to physical irritants.

Profound rhinorrhea.

Unilateral nasal symptoms, facial pain, thick green discharge, nosebleeds, or loss of smell warrant further assessment.[36]

INVESTIGATIONS

Allergen skin-prick testing: negative.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Nasal pruritus.

Ocular pruritus.

Excessive lacrimation.

INVESTIGATIONS

Nasal eosinophil smear: elevated.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

History of extended use of topical decongestants.

INVESTIGATIONS

No differentiating tests; diagnosis is clinical.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Pregnant.

INVESTIGATIONS

No differentiating tests; diagnosis is clinical.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Chronic rhinosinusitis.

Nasal obstruction.

Nasal discharge.

Facial pain/pressure.

Loss or decreased sense of smell.

INVESTIGATIONS

Anterior rhinoscopy or nasal endoscopy: polyps visualized.

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Can coexist with upper airway cough syndrome (UACS) or be an exacerbating factor.

Facial pain/pressure.

Nasal obstruction.

Nasal discharge.

Headache.

May be clinically silent.

INVESTIGATIONS

CT sinus: opacification of involved sinuses, mucosal thickening, air-fluid levels, or anatomical abnormalities.[Figure caption and citation for the preceding image starts]: CT sinus demonstrating opacification.Image courtesy of Mr Hesham Saleh; used with permission [Citation ends].com.bmj.content.model.Caption@1e9b1471

Use of this content is subject to our disclaimer